A Study of trastuzumab deruxtecan for patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prIor Trastuzumab-based regimen accompanied by a disease registry of patients treated with conventional therapies (PROSPERITY)

Project: Clinical studies › Clinical Study (Funded research)

Project Details

Description

A Study of trastuzumab deruxtecan for patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prIor Trastuzumab-based regimen accompanied by a disease registry of patients treated with conventional therapies (PROSPERITY)
StatusActive
Effective start/end date21.08.2024 → 31.12.2027

Fields of science

  • 302024 Haematology
  • 302055 Oncology